Gujarat, India

Kasimraza Baharooni

USPTO Granted Patents = 1 

Average Co-Inventor Count = 13.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Kasimraza Baharooni in Asymmetric Synthesis

Introduction

Kasimraza Baharooni is an accomplished inventor based in Gujarat, India. He has made significant contributions to the field of asymmetric synthesis, particularly in the development of azaspiro compounds. His innovative work has led to the filing of a patent that showcases his expertise and creativity in chemical synthesis.

Latest Patents

Kasimraza Baharooni holds a patent for the "Asymmetric synthesis of Azaspiro compounds." This invention relates to an improved method for synthesizing azaspiro or diazaspiro compounds and their pharmaceutically acceptable salts and derivatives. The process involves the formation of intermediate compounds through a highly diastereoselective and enantio-enriched approach. The method utilizes a cyclobutane carboxylate anion added to a Davis-Ellman's imine, followed by reduction and cyclization, resulting in the selective formation of the desired azaspiro or diazaspiro compounds.

Career Highlights

Kasimraza Baharooni is currently associated with Piramal Pharma Limited, where he continues to advance his research in pharmaceutical chemistry. His work has not only contributed to the scientific community but has also enhanced the capabilities of his organization in drug development.

Collaborations

Kasimraza has collaborated with notable colleagues such as Rajender Reddy Leleti and Yogesh Waman. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective fields.

Conclusion

Kasimraza Baharooni's contributions to asymmetric synthesis and his innovative patent demonstrate his commitment to advancing pharmaceutical chemistry. His work continues to inspire future research and development in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…